Inhibition of keratin 17 expression with antisense and RNAi strategies: Exploring novel therapy for psoriasis

Experimental Dermatology

Volumn 20, Issue 7, 2011, Pages 555-560

  Chang, Ting ^a   Sun, Linchao ^a   Wang, Yan ^a   Wang, Datai ^a   Li, Wei ^a   Li, Chunying ^a   Gao, Tianwen ^a   Liu, Yufeng ^a   Wang, Gang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antisense oligonucleotides; Keratin 17; Keratinocyte; RNA interference psoriasis

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYTOKERATIN 17; LIPOSOME; MESSENGER RNA; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE SILENCING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PSORIASIS; RNA INTERFERENCE; SKINFOLD THICKNESS;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EPIDERMIS; GENE EXPRESSION; HUMANS; KERATIN-17; KERATINOCYTES; MICE; MICE, SCID; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PSORIASIS; RNA, SMALL INTERFERING; SKIN; SKIN TRANSPLANTATION; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 79959512985     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2010.01235.x     Document Type: Article

References (19)

1. Nickoloff B J. Arch Dermatol 1999: 135: 1104-1110.
2. Nickoloff B J. Cutis 2000: 65: 110-114.
3. Trost A, Costa I, Jakab M et al. Exp Dermatol 2010: 19: e241-e250.
4. Telfer N R, Chalmers R J, Whale K et al. Arch Dermatol 1992: 128: 39-42.
5. Valdimarsson H, Baker B S, Jonsdottir I et al. Immunol Today 1995: 16: 145-149.
6. Leigh I M, Navsaria H, Purkis P E et al. Br J Dermatol 1995: 133: 501-511.
7. de Jong E M, van Vlijmen I M, van Erp P E et al. Arch Dermatol Res 1991: 283: 480-482.
8. Shen Z, Wang G, Fan J Y et al. J Dermatol Sci 2005: 38: 25-39.
9. Bonnekoh B, Bockelmann R. J Am Acad Dermatol 2007: 56: 162. Author reply 162-164.
10. Shen Z, Chen L, Liu Y F et al. J Am Acad Dermatol 2006: 54: 992-1002.
11. Jeong S H, Park J H, Kim J N et al. Exp Dermatol 2010: 19: e206-e212.
12. Wraight C J, White P J, McKean S C et al. Nat Biotechnol 2000: 18: 521-526.
13. Mehta R C, Stecker K K, Cooper S R et al. J Invest Dermatol 2000: 115: 805-812.
14. Hwang S M, Ahn S K, Menon G K et al. Int J Dermatol 2001: 40: 223-231.
15. Roberts M S. Clin Exp Pharmacol Physiol 1997: 24: 874-879.
16. Sioud M, Sorensen D R. Methods Mol Biol 2004: 252: 515-522.
17. Lieb L M, Liimatta A P, Bryan R N et al. J Pharm Sci 1997: 86: 1022-1029.
18. White P J, Fogarty R D, Liepe I J et al. J Invest Dermatol 1999: 112: 887-892.
19. Breaker R R. Nature 2004: 432: 838-845.